Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work -- a phenomenon called multidrug ...

Contrast agents are often used in diagnostic technologies like MRIs. There are many different types of contrast agents, which can make tissues much easier to see against the background fluids of the ...

A two-step nanoparticle system first blocks cancer cells' drug-expulsion mechanism, then releases chemotherapy combined with laser-driven heat to destroy resistant tumors.

A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center ...

A team led by Brent Wagner, MD, a professor in the University of New Mexico's School of Medicine Department of Internal Medicine, conducted a study published in the journal Magnetic Resonance Imaging.

Nanoparticles could enable gene therapies for cancer and genetic disease that don't use modified viruses, which may cause new forms of cancer or dangerous immune system reactions in some patients.

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.

Scientists have revealed a precocious nanotech discovery involving an ancient Roman artifact that predates the modern ...